TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares

(NYSE:TEN),(NYSE:TENPRE), ATHENS, Greece, Aug. 05, 2025 (GLOBE NEWSWIRE) — TEN Ltd. (“TEN”) (NYSE: TEN) (the “Company”), a leading diversified crude, product and LNG tanker operator, today announced that its Board of Directors declared the regular quarterly cash dividend of $0.578125 per share for its Series E Cumulative Perpetual Preferred Shares (the “Series E Preferred Shares”; […]

Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights

(NASDAQ:BMEA), Three presentations at ADA 2025 highlighted the therapeutic potential of icovamenib across multiple aspects of metabolic health: In patients with type 2 diabetes (T2D) not achieving glycemic targets, icovamenib demonstrated durable HbA1c reduction and improved beta-cell function subsequent to the dosing period In a rodent model of T2D, icovamenib in combination with low-dose semaglutide,

Appian To Participate in Upcoming Investor Conferences

(NasdaqGM:APPN), MCLEAN, Va., Aug. 05, 2025 (GLOBE NEWSWIRE) — Appian (Nasdaq: APPN), the leading platform for AI process automation, announced today that management will be presenting and hosting meetings with institutional investors at the following upcoming conferences: Keybanc Technology Leadership ForumMonday August 11, 2025A fireside chat is scheduled for 2:00pm Mountain Time and will be

Paylocity Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results

(NASDAQ:PCTY), Q4 2025 Recurring & Other Revenue of $369.9 million, up 14% year-over-year Q4 2025 Total Revenue of $400.7 million, up 12% year-over-year FY 2025 Recurring & Other Revenue of $1,471.8 million, up 15% year-over-year FY 2025 Total Revenue of $1,595.2 million, up 14% year-over-year Repurchased 800,000 shares of common stock for $150 million during

Cricut, Inc. Reports Second Quarter 2025 Financial Results

Cricut, Inc. Reports Second Quarter 2025 Financial Results GlobeNewswire August 05, 2025 Over 3 million Paid Subscribers, up 7% over Q2 2024 Q2 2025 revenue of $172.1 million, up 2% compared to Q2 2024 Net income of $24.5 million, up 24% compared to Q2 2024 SOUTH JORDAN, Utah, Aug. 05, 2025 (GLOBE NEWSWIRE) — Cricut,

LINEAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit – LINE

LINEAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit – LINE GlobeNewswire August 05, 2025 SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers of Lineage, Inc.

Noodles & Company Names Joseph D. Christina as President and CEO

Noodles & Company Names Joseph D. Christina as President and CEO GlobeNewswire August 05, 2025 Drew Madsen to Remain on Board of DirectorsReschedules Earnings Call For August 13th BROOMFIELD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) — Noodles & Company (Nasdaq: NDLS) today announced the promotion of Joseph D. Christina, the Company's current President and Chief

Flywire Reports Second Quarter 2025 Financial Results

Flywire Reports Second Quarter 2025 Financial Results GlobeNewswire August 05, 2025 Second Quarter Revenue Increased 27.2% Year-over-Year Second Quarter Revenue Less Ancillary Services Increased 27.7% Year-over-Year Previous Fiscal Year 2025 revenue guidance reaffirmed, aEBITDA margin guidance raised by 75 bps at midpoint BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) — Flywire Corporation (Nasdaq: FLYW) (“Flywire” or

Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12

(NASDAQ:TSHA), DALLAS, Aug. 05, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it will report its financial results for the second quarter ended June

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2025 Guidance

(NasdaqGM:AIP), CAMPBELL, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the second quarter ended June 30, 2025 and provided estimated third quarter and updated full year 2025 guidance. “In the second quarter of 2025, we

Scroll to Top